Activity value 72china Supplier,Last transaction date:
2026-06-15
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for hangzhou zhijiang meco pharmaceutical co ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 22 transactions, with a transaction quantity of 11773.5 and a transaction weight of 12209.3.
YearTransactionsQuantityWeight
20253021666.7573637.52
20262211773.512209.3
Bill of lading data
<
1/15
>
Trade date
2026/06/15
B/L No.
asshaa04026
Suppliers
hangzhou zhijiang meco pharmaceutical co ltd.
Buyers
pharmabest inc.
Product description
3010 TABLETS ERLOTINIB HYDROCHLORIDE TABLETS 150 MG GENERIC NAME ERLOTINIB AS HYDROCHLORIDE BRAND NAME ERLOX MANUFACTURER SHANDONG CONFUCIUS PHARMACEUTICAL CO LTD CHINA
Expand
Trade date
2026/05/06
B/L No.
asshaa01943
Suppliers
hangzhou zhijiang meco pharmaceutical co ltd.
Buyers
wellbest global corp
hangzhou zhijiang meco pharmaceutical co ltd. is china Supplier,
and primarily engages in the import and export business of products such as brand name,capsule,chi.
According to the 52wmb.com global trade database, as of 2026-06-15, the company has completed 88 international trades,
with its main trading regions covering philippines,ecuador,nigeria etc.
The core products include HS21069072000,HS3004902900,HS30049099000 etc,
often transported via manila,port qingdao, port san antonio etc,
and its main trading partners are pharmabest inc.,goodfellow pharma corp.,dreamax inc..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on hangzhou zhijiang meco pharmaceutical co ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.